{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:16:43Z","timestamp":1774894603802,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T00:00:00Z","timestamp":1472256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T00:00:00Z","timestamp":1472256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health","award":["R01AR064286"],"award-info":[{"award-number":["R01AR064286"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dystrophic epidermolysis bullosa (DEB), a rare genodermatosis, is characterized by the formation of intra-epidermal blistering and the development of chronic nonhealing skin wounds. Recently, attempts have been made to develop cell-based therapies for this currently intractable disorder. The molecular mechanisms that govern directional migration of the adult stem cells, allowing their efficient and controlled homing to the skin affected with DEB, are poorly understood. The key mechanism that regulates recruitment of leukocytes and progenitor stem cells to distal anatomical tissues affected with disease is chemotaxis, which depends on the signaling molecules, chemokines, and acts primarily as part of the host defense and repair mechanism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Comprehensive proteomic screening of chemokines in the blister fluids of DEB-affected mice was conducted to define the inflammatory and immune activities, thus providing potential to examine local biological mechanisms and define the protein signature within lesional skin as a potential marker of disease activity. Also, the therapeutic relevance of identified chemotactic pathways was investigated in vivo, providing a basis for future clinical investigations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Assessment of blister fluid-derived chemokines showed a persistent presence of several chemotactic molecules, including CXCL1\u2009+\u20092 and CXCL5. The majority of blister-originated chemotactic signals were associated with preferential recruitment of CD45<jats:sup>+<\/jats:sup>CXCR2<jats:sup>+<\/jats:sup> and CD11b<jats:sup>+<\/jats:sup>CXCR2<jats:sup>+<\/jats:sup> leukocytes. Systemic transplantation of an enriched CXCR2 population of mouse adipose-derived stem cells (mADSC) into DEB-affected mice demonstrated effective recruitment of cells to the blistering skin under the influence of blister-derived ligands and deposition of therapeutic type VII collagen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Collectively, these studies demonstrate that recruitment of mADSC into DEB skin is tightly controlled by disease-site chemotactic activities and suggest a potential mechanism for effective application of therapeutic stem cells for DEB.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-016-0388-y","type":"journal-article","created":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T02:55:56Z","timestamp":1472266556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Chemotaxis-driven disease-site targeting of therapeutic adult stem cells in dystrophic epidermolysis bullosa"],"prefix":"10.1186","volume":"7","author":[{"given":"Vitali","family":"Alexeev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jouni","family":"Uitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9813-7184","authenticated-orcid":false,"given":"Olga","family":"Igoucheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,27]]},"reference":[{"key":"388_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jaad.2008.02.004","volume":"58","author":"JD Fine","year":"2008","unstructured":"Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, Hintner H, Hovnanian A, Jonkman MF, Leigh I, McGrath JA, Mellerio JE, Murrell DF, Shimizu H, Uitto J, Vahlquist A, Woodley D, Zambruno G. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 2008;58:931\u201350.","journal-title":"J Am Acad Dermatol."},{"key":"388_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jid.2015.10.050","volume":"136","author":"J Uitto","year":"2016","unstructured":"Uitto J, Bruckner-Tuderman L, Christiano AM, McGrath JA, Has C, South AP, Kopelan B, Robinson EC. Progress toward treatment and cure of epidermolysis bullosa: summary of the DEBRA international research symposium EB 2015. J Invest Dermatol. 2016;136:352\u20138.","journal-title":"J Invest Dermatol."},{"key":"388_CR3","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.exphem.2005.07.003","volume":"33","author":"W Wagner","year":"2005","unstructured":"Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, Blake J, Schwager C, Eckstein V, Ansorge W, Ho AD. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol. 2005;33:1402\u201316.","journal-title":"Exp Hematol."},{"key":"388_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1634\/stemcells.2004-0304","volume":"23","author":"JA Jeong","year":"2005","unstructured":"Jeong JA, Hong SH, Gang EJ, Ahn C, Hwang SH, Yang IH, Han H, Kim H. Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray. Stem Cells. 2005;23:584\u201393.","journal-title":"Stem Cells."},{"key":"388_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1634\/stemcells.21-6-661","volume":"21","author":"WA Silva Jr","year":"2003","unstructured":"Silva Jr WA, Covas DT, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL, Santos AR, Zago MA. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells. 2003;21:661\u20139.","journal-title":"Stem Cells."},{"key":"388_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/scrt411","volume":"5","author":"V Alexeev","year":"2014","unstructured":"Alexeev V, Arita M, Donahue A, Bonaldo P, Chu ML, Igoucheva O. Human adipose-derived stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophy. Stem Cell Res Ther. 2014;5:21.","journal-title":"Stem Cell Res Ther."},{"key":"388_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jcyt.2012.11.006","volume":"15","author":"V Alexeev","year":"2013","unstructured":"Alexeev V, Donahue A, Uitto J, Igoucheva O. Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues. Cytotherapy. 2013;15:171\u201384. e1.","journal-title":"Cytotherapy"},{"key":"388_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3109\/14653249.2010.518609","volume":"13","author":"V Alexeev","year":"2011","unstructured":"Alexeev V, Uitto J, Igoucheva O. Gene expression signatures of mouse bone marrow-derived mesenchymal stem cells in the cutaneous environment and therapeutic implications for blistering skin disorder. Cytotherapy. 2011;13:30\u201345.","journal-title":"Cytotherapy."},{"key":"388_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa0910501","volume":"363","author":"JE Wagner","year":"2010","unstructured":"Wagner JE, Ishida-Yamamoto A, McGrath JA, Hordinsky M, Keene DR, Woodley DT, Chen M, Riddle MJ, Osborn MJ, Lund T, Dolan M, Blazar BR, Tolar J. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med. 2010;363:629\u201339.","journal-title":"N Engl J Med."},{"key":"388_CR10","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1038\/jid.2015.158","volume":"135","author":"G Petrof","year":"2015","unstructured":"Petrof G, Lwin SM, Martinez-Queipo M, Abdul-Wahab A, Tso S, Mellerio JE, Slaper-Cortenbach I, Boelens JJ, Tolar J, Veys P, Ofuya M, Peacock JL, Martinez AE, McGrath JA. Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2015;135:2319\u201321.","journal-title":"J Invest Dermatol."},{"key":"388_CR11","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/jid.2011.85","volume":"131","author":"N Nagy","year":"2011","unstructured":"Nagy N, Almaani N, Tanaka A, Lai-Cheong JE, Techanukul T, Mellerio JE, McGrath JA. HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa. J Invest Dermatol. 2011;131:1771\u20134.","journal-title":"J Invest Dermatol."},{"key":"388_CR12","doi-asserted-by":"publisher","first-page":"25476","DOI":"10.3390\/ijms161025476","volume":"16","author":"N Ojeh","year":"2015","unstructured":"Ojeh N, Pastar I, Tomic-Canic M, Stojadinovic O. Stem cells in skin regeneration, wound healing, and their clinical applications. Int J Mol Sci. 2015;16:25476\u2013501.","journal-title":"Int J Mol Sci."},{"key":"388_CR13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1517\/14712598.2015.1053867","volume":"15","author":"Y Shingyochi","year":"2015","unstructured":"Shingyochi Y, Orbay H, Mizuno H. Adipose-derived stem cells for wound repair and regeneration. Expert Opin Biol Ther. 2015;15:1285\u201392.","journal-title":"Expert Opin Biol Ther."},{"key":"388_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1517\/14712598.2012.657174","volume":"12","author":"MZ Ratajczak","year":"2012","unstructured":"Ratajczak MZ, Kim C. The use of chemokine receptor agonists in stem cell mobilization. Expert Opin Biol Ther. 2012;12:287\u201397.","journal-title":"Expert Opin Biol Ther."},{"key":"388_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1586\/ehm.11.54","volume":"4","author":"GK Melve","year":"2011","unstructured":"Melve GK, Ersvssr E, Kittang AO, Bruserud O. The chemokine system in allogeneic stem-cell transplantation: a possible therapeutic target? Expert Rev Hematol. 2011;4:563\u201376.","journal-title":"Expert Rev Hematol."},{"key":"388_CR16","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1634\/stemcells.2005-0319","volume":"24","author":"M Honczarenko","year":"2006","unstructured":"Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells. 2006;24:1030\u201341.","journal-title":"Stem Cells."},{"key":"388_CR17","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","volume":"25","author":"G Chamberlain","year":"2007","unstructured":"Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25:2739\u201349.","journal-title":"Stem Cells."},{"key":"388_CR18","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.yexcr.2008.12.022","volume":"315","author":"T Binger","year":"2009","unstructured":"Binger T, Stich S, Andreas K, Kaps C, Sezer O, Notter M, Sittinger M, Ringe J. Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25. Exp Cell Res. 2009;315:1468\u201379.","journal-title":"Exp Cell Res."},{"key":"388_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.biocel.2008.07.011","volume":"41","author":"G Kalwitz","year":"2009","unstructured":"Kalwitz G, Endres M, Neumann K, Skriner K, Ringe J, Sezer O, Sittinger M, Haupl T, Kaps C. Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7. Int J Biochem Cell Biol. 2009;41:649\u201358.","journal-title":"Int J Biochem Cell Biol."},{"key":"388_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00441-009-0768-z","volume":"336","author":"S Stich","year":"2009","unstructured":"Stich S, Haag M, Haupl T, Sezer O, Notter M, Kaps C, Sittinger M, Ringe J. Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12. Cell Tissue Res. 2009;336:225\u201336.","journal-title":"Cell Tissue Res."},{"key":"388_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jcb.21172","volume":"101","author":"J Ringe","year":"2007","unstructured":"Ringe J, Strassburg S, Neumann K, Endres M, Notter M, Burmester GR, Kaps C, Sittinger M. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem. 2007;101:135\u201346.","journal-title":"J Cell Biochem."},{"key":"388_CR22","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1158\/1535-7163.MCT-06-0709","volume":"6","author":"L Novak","year":"2007","unstructured":"Novak L, Igoucheva O, Cho S, Alexeev V. Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication. Mol Cancer Ther. 2007;6:1755\u201364.","journal-title":"Mol Cancer Ther."},{"key":"388_CR23","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.ajpath.2011.02.031","volume":"178","author":"NJ Tubo","year":"2011","unstructured":"Tubo NJ, McLachlan JB, Campbell JJ. Chemokine receptor requirements for epidermal T-cell trafficking. Am J Pathol. 2011;178:2496\u2013503.","journal-title":"Am J Pathol."},{"key":"388_CR24","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/sj.jid.5700069","volume":"126","author":"S Avniel","year":"2006","unstructured":"Avniel S, Arik Z, Maly A, Sagie A, Basst HB, Yahana MD, Weiss ID, Pal B, Wald O, Ad-El D, Fujii N, Arenzana-Seisdedos F, Jung S, Galun E, Gur E, Peled A. Involvement of the CXCL12\/CXCR4 pathway in the recovery of skin following burns. J Invest Dermatol. 2006;126:468\u201376.","journal-title":"J Invest Dermatol."},{"key":"388_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1600-0714.2006.00402.x","volume":"35","author":"M Ichimura","year":"2006","unstructured":"Ichimura M, Hiratsuka K, Ogura N, Utsunomiya T, Sakamaki H, Kondoh T, Abiko Y, Otake S, Yamamoto M. Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus. J Oral Pathol Med. 2006;35:167\u201374.","journal-title":"J Oral Pathol Med."},{"key":"388_CR26","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/art.21034","volume":"52","author":"S Meller","year":"2005","unstructured":"Meller S, Winterberg F, Gilliet M, Muller A, Lauceviciute I, Rieker J, Neumann NJ, Kubitza R, Gombert M, Bunemann E, Wiesner U, Franken-Kunkel P, Kanzler H, Dieu-Nosjean MC, Amara A, Ruzicka T, Lehmann P, Zlotnik A, Homey B. Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: an amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum. 2005;52:1504\u201316.","journal-title":"Arthritis Rheum."},{"key":"388_CR27","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.4049\/jimmunol.180.4.2581","volume":"180","author":"M Sasaki","year":"2008","unstructured":"Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008;180:2581\u20137.","journal-title":"J Immunol."},{"key":"388_CR28","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1242\/jcs.112.21.3641","volume":"112","author":"S Heinonen","year":"1999","unstructured":"Heinonen S, Mannikko M, Klement JF, Whitaker-Menezes D, Murphy GF, Uitto J. Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J Cell Sci. 1999;112:3641\u20138.","journal-title":"J Cell Sci."},{"key":"388_CR29","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1172\/JCI34292","volume":"118","author":"A Fritsch","year":"2008","unstructured":"Fritsch A, Loeckermann S, Kern JS, Braun A, Bosl MR, Bley TA, Schumann H, von Elverfeldt D, Paul D, Erlacher M, Berens von Rautenfeld D, Hausser I, Fassler R, Bruckner-Tuderman L. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest. 2008;118:1669\u201379.","journal-title":"J Clin Invest."},{"key":"388_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3109\/14653241003587637","volume":"12","author":"P Conget","year":"2010","unstructured":"Conget P, Rodriguez F, Kramer S, Allers C, Simon V, Palisson F, Gonzalez S, Yubero MJ. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy. 2010;12:429\u201331.","journal-title":"Cytotherapy."},{"key":"388_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/dth.12305","volume":"29","author":"M El-Darouti","year":"2016","unstructured":"El-Darouti M, Fawzy M, Amin I, Hay RA, Hegazy R, Gabr H, El Maadawi Z. Treatment of dystrophic epidermolysis bullosa with bone marrow non-hematopoeitic stem cells: a randomized controlled trial. Dermatol Ther. 2016;29:96\u2013100.","journal-title":"Dermatol Ther."},{"key":"388_CR32","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1084\/jem.20071397","volume":"204","author":"K Hirota","year":"2007","unstructured":"Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, Yamaguchi T, Nomura T, Ito H, Nakamura T, Sakaguchi N, Sakaguchi S. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med. 2007;204:2803\u201312.","journal-title":"J Exp Med."},{"key":"388_CR33","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1053\/j.gastro.2008.02.085","volume":"134","author":"M Apostolaki","year":"2008","unstructured":"Apostolaki M, Manoloukos M, Roulis M, Wurbel MA, Muller W, Papadakis KA, Kontoyiannis DL, Malissen B, Kollias G. Role of beta7 integrin and the chemokine\/chemokine receptor pair CCL25\/CCR9 in modeled TNF-dependent Crohn\u2019s disease. Gastroenterology. 2008;134:2025\u201335.","journal-title":"Gastroenterology."},{"key":"388_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1517\/14712598.2011.546338","volume":"11","author":"TT Lau","year":"2011","unstructured":"Lau TT, Wang DA. Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. Expert Opin Biol Ther. 2011;11:189\u201397.","journal-title":"Expert Opin Biol Ther."},{"key":"388_CR35","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1365-2133.2007.08240.x","volume":"157","author":"A Toksoy","year":"2007","unstructured":"Toksoy A, Muller V, Gillitzer R, Goebeler M. Biphasic expression of stromal cell-derived factor-1 during human wound healing. Br J Dermatol. 2007;157:1148\u201354.","journal-title":"Br J Dermatol."},{"key":"388_CR36","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.4049\/jimmunol.1400914","volume":"194","author":"S Iinuma","year":"2015","unstructured":"Iinuma S, Aikawa E, Tamai K, Fujita R, Kikuchi Y, Chino T, Kikuta J, McGrath JA, Uitto J, Ishii M, Iizuka H, Kaneda Y. Transplanted bone marrow-derived circulating PDGFRalpha\u2009+\u2009cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft. J Immunol. 2015;194:1996\u20132003.","journal-title":"J Immunol."},{"key":"388_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1272\/jnms.80.140","volume":"80","author":"F Josh","year":"2013","unstructured":"Josh F, Tobita M, Tanaka R, Orbay H, Ogata K, Suzuki K, Hyakusoku H, Mizuno H. Concentration of PDGF-AB, BB and TGF-beta1 as valuable human serum parameters in adipose-derived stem cell proliferation. J Nippon Med Sch. 2013;80:140\u20137.","journal-title":"J Nippon Med Sch."},{"key":"388_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2217\/rme.09.74","volume":"5","author":"PR Baraniak","year":"2010","unstructured":"Baraniak PR, McDevitt TC. Stem cell paracrine actions and tissue regeneration. Regen Med. 2010;5:121\u201343.","journal-title":"Regen Med."},{"key":"388_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/scrt511","volume":"5","author":"C Perdoni","year":"2014","unstructured":"Perdoni C, McGrath JA, Tolar J. Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa. Stem Cell Res Ther. 2014;5:121.","journal-title":"Stem Cell Res Ther."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0388-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-016-0388-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0388-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0388-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T06:19:41Z","timestamp":1637043581000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-016-0388-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,27]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1186\/s13287-016-0388-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,27]]},"assertion":[{"value":"27 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"124"}}